Back
  1. Home
  2. Request Item
institution logo
If you're member of the institution,  you just have to login to download the file in restricted access. It is not necessary to request a print.

Request copy

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
Dandona, P.; Mathieu, C.; Phillip, M. et al.
2017 • In The Lancet Diabetes and Endocrinology, 5 (11), p. 864-876

Document(s) requested
Dandona DEPICT1 Dapagliflozin in type 1 diabetes Lancet 2017.pdf

The desired document is not currently available on open access. Nevertheless you can request an offprint through the form below. If your request is accepted you will receive by e-mail a link allowing you access to the document for 5 days, 5 download attempts maximum.


Request form

Fields marked with ✱ are compulsory.

Back to the reference
Contact ORBi